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ABSTRACT 
Objective: To determine the prevalence of sexually transmitted 
diseases in female athletes. Methods: An observational, cross-
sectional study was conducted including 50 female athletes with 
mean age of 20±3 years. Colposcopy, pap smear, and polymerase 
chain reaction for Chlamydia trachomatis, human papillomavirus 
and Neisseria gonorrhoeae were performed. Blood samples were 
collected to test for the human immunodeficiency virus, syphilis, 
hepatitis B and C. The athletes presenting clinical diseases or 
conditions identifiable by laboratory tests were treated and followed 
up in the unit. Results: Forty-six percent of the participants were 
unaware of sexually transmitted diseases. The prevalence of sexually 
transmitted diseases among athletes was 48% (24 cases). Human 
papillomavirus was the most frequent agent (44%). Considering 
the human papillomavirus genotypes, subtype 16 was the most 
prevalent (53%), followed by 11-6 (22%) and 18 (13%). Two athletes 
tested positive for C. trachomatis. There were no cases diagnosed 
of infection by N. gonorrhoeae, syphilis, hepatitis B, hepatitis C and 
human immunodeficiency virus. However, only 26 athletes had been 
vaccinated for hepatitis B. Conclusion: The prevalence of sexually 
transmitted diseases in female athletes was high. Primary prevention 
measures (hepatitis B and human papillomavirus vaccination) and 
secondary (serology, pap smears) must be offered to this specific 
group of women. The matter should be further approached in sports.
Keywords: Sports medicine; Sexually transmitted diseases; Vaginal 
smears; Papillomavirus infections; Real-time polymerase chain reaction
RESUMO
Objetivo: Determinar a prevalência de doenças sexualmente transmissíveis 
em mulheres atletas. Métodos: Estudo observacional, de corte 
transversal, que incluiu 50 mulheres atletas com idade média de 20±3 
anos. Realizaram-se colposcopia, coleta de colpocitologia oncótica 
cérvico-vaginal e pesquisa para Chlamydia trachomatis, papilomavírus 
humano e Neisseria gonorrhoeae, pelo método do reação de cadeia 
de polimerase. Amostras de sangue foram obtidas para pesquisa de 
vírus da imunodeficiência humana, sífilis, hepatite B e C. As atletas 
que apresentaram doenças clínicas ou laboratorialmente identificáveis 
receberam tratamento e acompanhamento no serviço. Resultados: 
Dentre as participantes, 46% relataram desconhecimento acerca 
das doenças sexualmente transmissíveis. A frequência de doenças 
sexualmente transmissíveis nas atletas foi de 48% (24 casos). 
Isoladamente, o papilomavírus humano foi o agente mais frequente 
(44%). Considerando o tipo de genótipo do papilomavírus humano, o 
subtipo 16 foi o mais prevalente (53%), seguido do 6-11 (22%) e do 18 
(13%). Duas atletas tiveram resultado positivo para C. trachomatis. Não 
foi diagnosticado nenhum caso de infecção por N. gonorrhoeae, sífilis, 
hepatite B, hepatite C e vírus da imunodeficiência humana. Contudo, 
somente 26 atletas haviam sido vacinadas para hepatite B. Conclusão: A 
prevalência de doenças sexualmente transmissíveis em mulheres atletas 
foi elevada. Medidas de prevenção primária (vacinação para hepatite B e 
papilomavírus humano) e secundária (sorologias e colpocitologia) devem 
ser fornecidas a esse grupo específico de mulheres. O assunto deve ser 
abordado no meio desportivo.
Descritores: Medicina esportiva; Doenças sexualmente transmissíveis; 
Esfregaço vaginal; Infecções por papillomavírus; Reação em cadeia 
da polimerase em tempo real
INTRODUCTION
In 1991, basketball player Magic Johnson announced he 
had acquired immunodeficiency syndrome, commonly 
known as AIDS. The news had a major impact on the 
sports world, and many of his teammates began to get 
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tested, because they were afraid of having acquired the 
disease.(1) The truth is that up to this event, athletes 
were seen as super-heroes and little was known on the 
risk of acquiring sexually transmitted diseases (STD) 
while practicing sports and what was the prevalence of 
these conditions in athletes. The risk of contamination 
is currently known to be very low and the possibility lies 
on the presence of bleeding wounds.(2,3)
The risk of transmission of the human immunodeficiency 
virus (HIV) may occur in some contact sports, such 
as wrestling, taekwondo, box and American football.
(2) However, the risk is extremely low, estimated to be 
around 1/85 million games.(3,4) Conversely, transmission 
through contaminated syringes in athletes who use illicit 
drugs (doping), has been associated to several sports 
modalities.(5) 
The risk of transmission of the hepatitis B virus is 50-
fold greater than of the HIV virus. This occurs because 
the virus is resistant to drying, room temperature, to 
detergents and to alcohol, in addition to being stable 
on surfaces, during at least 7 days. Therefore, the 
transmission of hepatitis B in sports is estimated at 
about 1/10 thousand to 1/50 thousand games.(2) 
Regarding hepatitis C, there have been reports on 
former football players that used injections of vitamin 
complexes.(6-8) 
STD are among the five major causes for seeking 
medical care and the second major cause of not having 
a healthy lifestyle among women.(9,10) Although most 
conditions are curable, many lesions increase the risk 
of HIV infection three-fold and others are precursors 
of neoplasms – such as human papillomavirus (HPV), 
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae 
(NG) infections (7). 
Some studies appointed a positive association between 
being an athlete and having risky sexual behavior.(11,12) 
Young athletes begin contact with the opposite sex 
early, on competition trips, and the lack of knowledge on 
transmission of STD makes many of them not practice 
safe sex.(13) Moreover, this population has a greater 
consumption of anabolic substances and a higher number 
of sexual partners.(14-16) 
High performance athletes and, especially those 
in team sports, have little perception of risks, and also 
engage in non-programmed sexual activity.(17) In soccer, 
over 80% of players declare acknowledging HIV but 
few (20%) know about other STD.(18) They also have 
questions on how the virus is transmitted, given many 
believe in contamination by exchanging shirts and 
kissing.(18) 
In recent years, professionals who work with athletes 
have proposed STD screening at the beginning of every 
season, using a pre-participation sports assessment 
(PPSA).(19) It would be a timely moment for detecting 
these diseases, treating them whenever necessary, and 
counseling on means of prevention. 
OBJECTIVE
To determine the prevalence of sexually transmitted 
diseases among women athletes
METHODS
An observational, cross-sectional study was performed 
at the Sports Gynecology Sector of the Escola Paulista 
de Medicina da Universidade Federal de São Paulo 
(UNIFESP), from January to July 2011. The Project was 
approved by the Ethics Committee of the institution, 
under number 1,269/08. All participants read and signed 
the consent form. 
Investigators went to the athletes’ training site 
and explained the objective of the study. Those who 
agreed to participate answered a questionnaire that 
emphasized gynecological data (age at menarche, 
characteristics of the menstrual cycle, contraceptive 
methods, past sexual and obstetric history and history 
of STD). Athletes, family members and coaches were 
offered talks on STD/AIDS on the training site and, 
after answering questions, athletes were invited to come 
to the outpatient clinic, where they would be seen by a 
gynecologist. 
Women who practiced performance sports in Olympic 
modalities of the International Olympic Committee 
(IOC) were considered athletes. All of them had been 
federation affiliates for at least three years and had a 
mean training load of 20 hours/week. 
At the outpatient clinic, blood samples (to diagnose 
syphilis, HIV, hepatitis B and hepatitis C) were drawn, 
and cervical and vaginal secretion were collected during 
colposcopy (for pap smear, CT, NG and HPV tests). 
A biopsy of the lower genital tract was done whenever 
necessary. 
The flocculation method was used (VDRL), along 
with the titer for syphilis; whenever necessary the result 
was confirmed by passive hemagglutination methods 
(HTPA) and EIE (ELISA). 
HIV was diagnosed by two ELISA tests. If any of 
the two were positive, immunofluorescence tests were 
performed. If a question remained a Western blot test 
was performed. 
ELISA was used for hepatitis B serology, using 
the following the algorithm: determination of titers 
of HBs antigen and total anti-HBc antibodies. If both 
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were negative, the result was considered negative. If 
the HBsAg was negative and total Anti-HBc positive, 
an anti-HBs antibody detection test was performed, 
and the positive result indicated immunity or previous 
hepatitis B infection. 
Serology for hepatitis C used two techniques: 
EIA-Hepanostika® qualitative immunoenzyme test 
and MONOLISATM anti-HCV plus, an indirect 
immunoenzyme test. 
Regarding cervical and vaginal samples, results 
with superficial, intermediate squamous cells and/or 
endocervical cells without abnormalities were considered 
normal cytology, as were those with squamous metaplasia 
and/or with inflammatory changes. A diagnosis of low 
grade lesion, high grade lesion, squamous carcinoma, 
squamous cell atypia of undetermined significance and 
glandular atypia of undetermined significance were 
considered abnormal cytology. 
Real time polymerase chain reaction (PCR) was 
used to test for CT, NG and HPV. All athletes with 
clinical or identifiable laboratory diseases were treated 
and followed up at the service.
 The population was analyzed as to age, race 
and sports modality. The following gynecological data 
were analyzed: age at menarche, menstrual cycles, 
contraceptive method, and number of pregnancies 
and of deliveries. Analysis of variables was descriptive. 
Minimum and maximum values, medians, means and 
standard deviations were used for quantitative variables. 
RESULTS
Fifty athletes with a mean age of 20±3 years were 
assessed. Of the total, 66% declared themselves as white 
and 34% as non-white. As to socioeconomic status, 
35% of participants had completed College, 11% High 
School and 4% Elementary School. Monthly family 
income ranged between R$ 370.00 and R$ 2,100.00.
Table 1 shows the characteristics of the sample as to 
sports modality and to choice of contraceptive method. 
Most participants (40%) took part in athletics and 
martial arts (36%) teams. Regarding contraception, 29 
athletes used oral hormone contraceptives, 12 athletes 
used male condoms and 6 athletes did not use any 
method. As to gynecological data, the mean age of 
menarche was 13±1 years, with a minimum of 9 and 
maximum of 15 years. Regular menstrual cycles were 
reported by 82% of athletes and 18% had irregular 
menstrual cycles. Regarding parity, 90% were nullipara. 
When each athlete was asked on knowledge of STD, 
46% declared not having knowledge on such conditions, 
and five athletes reported a previous HPV infection.
The prevalence of STD among athletes analyzed 
was 48% (24 cases). HPV was the most frequent agent 
(44%) and, considering mixed infections, there was a case 
of CT com HPV. No cases of infection by NG, or syphilis, 
hepatitis B, hepatitis C and HIV were diagnosed (Table 2). 
Table 1. Distribution of sports modality and contraceptive methods
Variables n (%)
Sports modality
Athletics 20 (40)
Martial arts 18 (36)
Basketball 1 (2)
Dance 3 (6)
Indoor soccer 2 (4)
Handball 4 (8)
Sychonized swimming 1 (2)
Swimming 1 (2)
Contraceptive method 
Oral hormone contraceptive 29 (58)
Male condom 12 (24)
Female condom 1 (2)
Monthly injectable 1 (2)
IUD 1 (2)
No method 6 (12)
IUD: progesterone releasing intrauterine system.
Table 2. Prevalence of sexually transmitted diseases, alone or associated
STD n (%)
HPV 22 (44)
Chlamydia 1 (2)
Gonorrhoeae 0 (0)
Syphilis 0 (0)
HIV 0 (0)
Hepatitis B 0 (0)
Hepatitis C 0 (0)
HPV+Chlamydia 1 (2)
STD: sexually transmitted diseases; HPV: human papillomavirus; HIV: human immunodeficiency virus.
Regarding the type of HPV genotype, that was 
detected in 23 of 50 women athletes, subtype 16 was the 
most prevalent (53%), followed by 6-11 (22%) and by 
18 (13%) (Table 3). 
Although no cases of hepatitis B were detected, 24 
(48%) athletes were not immune to hepatitis B virus 
(negative anti-HBs). 
Three athletes presented low grade cervical lesions 
and one athlete had a high grade lesion detected by the 
cervical-vaginal cytology.
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DISCUSSION
Although muscle-skeletal lesions are strongly associated 
with exercising, infectious diseases cause significant 
morbidity among athletes.(20) The results of the present 
study alert on the importance of measures to explain 
and orient about STD in sports, given half of athletes 
had no knowledge on these conditions. 
The sports environment has a distorted image of 
being healthy and with no risk behaviors. Several 
authors appointed toward an excessive use of alcohol, 
tobacco, illicit drugs and unprotected sex among young 
athletes.(21) Moreover, premature initiation of sex life 
and of non-programmed intercourse contribute to 
the growth in susceptibility to STD infections and to 
unwanted pregnancy.(12,22)
The general prevalence of STD among athletes was 
high, and the isolated or associated occurrence with 
HPV should be underscored. The prevalence of the 
HPV genotype with high risk for cervical cancer is also 
worth mentioning.(16,18) 
The prevalence of HPV among asymptomatic 
women seen at public gynecological clinics, using the 
PCR method, is about 16% − much lower than the 
values found among athletes.(23) A possible explanation 
would be the complex interaction between the immune 
system and exercise. In general, moderate intensity 
exercise promotes protection against infections, because 
it drives cell immune response (mainly of type 1 T-helper 
− Th1 cells). However, high intensity activities generate 
increase in the concentrations of anti-inflammatory 
cytokines (type 2 T-helper − Th2), increasing susceptibility 
to infections.(24) 
The higher prevalence of oncogenic HPVs among 
athletes was a concerning finding. Epidemiological 
studies showed that HPV 16 is responsible for most 
cervical neoplasms, followed by HPV 18. HPVs 6 and 
11 account for 90% of genital warts. Although infection 
by oncogenic HPV is a necessary condition to develop 
cervical cancer, it is insufficient. In two years, the 
infection reverts spontaneously in almost 90% of cases. 
Moreover, the progression of infection to cervical 
cancer is very slow and controllable. Thus, cervical 
cancer screening, using pap smears, should be part of 
the routine for young athletes, along with other routine 
tests requested regularly by sports physicians. 
HPV vaccination is part of the recommendations 
proposed by the Brazilian Federation of Gynecology 
and Obstetrics Societies (FEBRASGO) and by the 
Brazilian Association of Immunizations (SBIm) and 
should be better promoted among athletes. A timely 
moment to offer vaccination would be PPSA.
The United States and Australia have put in place 
routine tests for CT and gonorrhea during the PPSA.(25) 
In one of the studies with 9 to 12-year-old boys and girls, 
the prevalence of CT in girls was 6.5% and of gonorrhea 
2.0%.(26) In another study, the general prevalence of 
CT among athletes was 2.7% (3.2% men and 2.2% 
women).(27) In our study, the prevalence of CT was in 
agreement with the literature, highlighting that one of 
the athletes had a co-infection with the HPV virus. 
CT infections have a high morbidity and also have 
a preference for youth between 15 and 29 years. 
Considered as having a silent epidemiology, its diagnosis 
is critical, given the infection is asymptomatic in almost 
80% of cases. One of the problems of persistent 
infection by Chlamydia is its cervical carcinogenesis 
capacity, which occurs through proteins synthetized 
by bacteria.(28) These proteins have an anti-apoptotic 
action during persistent infection, which eases the 
action of oncoproteins on cells simultaneously infected 
by high risk HPV (HPV types 16 and 18).(28) Another 
severe sequela is pelvic inflammatory disease which can 
lead to ectopic pregnancy and to infertility.(29) 
There is a consensus that the major means of 
transmission of STD among athletes is not while 
practicing sports, but similar to the general population 
– by unprotected sex and exchange of contaminated 
syringes.(30) Therefore, the prevention of these infections 
is still one of the most efficacious and less costly measures 
that exist.(31) 
The major international organizations for athletes 
have stimulated hepatitis B vaccination, contact sports 
judges wearing gloves, the interruption of a game when 
there is a bleeding lesion and the education of coaches, 
fitness coaches and athletes on STD/AIDS. 
Athletes should be asked about their knowledge 
and difficulties regarding sexuality and prevention of 
STD, which would also mean helping them to deal with 
their own vulnerability.
As the sports world is a strong information media, 
capable of spreading several topics to the general 
population, athletes with appropriate knowledge of 
STD may boost the importance of using preventive 
Table 3. Type of human papillomavirus genotype 
HPV type n (%)
16 12 (53)
18 3 (13)
6-11 5 (22)
53 1 (3)
66* 2 (9)
* One of the athletes with HPV genotype 66 also had a positive result for chlamydia. HPV: human papillomavirus.
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measures, such as safe sex and vaccination for some 
diseases.
CONCLUSIONS 
The prevalence of sexually transmitted diseases in female 
athletes analyzed was high and the human papillomavirus 
was the most frequent agent. Results point toward the 
vulnerability of athletes to sexually transmitted diseases 
and toward the need for primary (hepatitis B and human 
papillomavirus vaccination) and secondary (serology, 
colposcopy and cytology) prevention measures in this 
specific group of women. 
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